Searchable abstracts of presentations at key conferences in endocrinology

ea0026p205 | Pituitary | ECE2011

LHRH-antagonist cetrorelix may reduce postmenopausal flushing

van Gastel P M , van der Zanden M , Telting D , Filius M , Bansci L , de Boer H

Background: Estrogen replacement therapy is the most effective treatment for postmenopausal (PMP) flushing, but its use is often contraindicated. An effective and safe alternative is urgently needed.Aim: To explore the effects of the LHRH receptor antagonist cetrorelix in women with severe PMP flushing who have a mean daily flush score >15.Methods: Open-label treatment with cetrorelix 250 μg twice a day in nine women with ...